(NASDAQ: ATAI) Atai Life Sciences Nv's forecast annual revenue growth rate of 68.42% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Atai Life Sciences Nv's revenue in 2024 is $314,000.On average, 1 Wall Street analysts forecast ATAI's revenue for 2024 to be $249,039,594, with the lowest ATAI revenue forecast at $249,039,594, and the highest ATAI revenue forecast at $249,039,594. On average, 1 Wall Street analysts forecast ATAI's revenue for 2025 to be $249,039,594, with the lowest ATAI revenue forecast at $249,039,594, and the highest ATAI revenue forecast at $249,039,594.
In 2026, ATAI is forecast to generate $249,039,594 in revenue, with the lowest revenue forecast at $249,039,594 and the highest revenue forecast at $249,039,594.